Skip to main content

Brief report: Risk of adverse fetal outcomes associated with immunosuppressive medications for chronic immune-mediated diseases in pregnancy.


AUTHORS

Cooper WO , Cheetham TC , Li DK , Stein CM , Callahan ST , Morgan TM , Shintani AK , Chen N , Griffin MR , Ray WA , . Arthritis & rheumatology (Hoboken, N.J.). 2014 2 1; 66(2). 444-50

ABSTRACT

To assess the risk of adverse fetal outcomes following exposure to individual immunosuppressive drugs in pregnant women with chronic immune-mediated diseases.


To assess the risk of adverse fetal outcomes following exposure to individual immunosuppressive drugs in pregnant women with chronic immune-mediated diseases.


Tags: